$56.99
0.99%
Nasdaq, Apr 21, 07:44 pm CET
ISIN
US4364401012
Symbol
HOLX

Hologic Stock price

$57.56
-4.26 6.89% 1M
-22.91 28.47% 6M
-14.53 20.16% YTD
-17.36 23.17% 1Y
-17.62 23.44% 3Y
+13.77 31.45% 5Y
+25.10 77.30% 10Y
Nasdaq, Closing price Thu, Apr 17 2025
+1.06 1.88%
ISIN
US4364401012
Symbol
HOLX
Sector

Key metrics

Market capitalization $12.92b
Enterprise Value $13.48b
P/E (TTM) P/E ratio 18.21
EV/FCF (TTM) EV/FCF 11.93
EV/Sales (TTM) EV/Sales 3.34
P/S ratio (TTM) P/S ratio 3.20
P/B ratio (TTM) P/B ratio 2.72
Revenue growth (TTM) Revenue growth 1.75%
Revenue (TTM) Revenue $4.04b
EBIT (operating result TTM) EBIT $977.20m
Free Cash Flow (TTM) Free Cash Flow $1.13b
Cash position $1.97b
EPS (TTM) EPS $3.16
P/E forward 16.04
P/S forward 3.17
EV/Sales forward 3.31
Short interest 3.83%
Show more

Is Hologic a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,780 stocks worldwide.

Hologic Stock Analysis

Unlock Scores for Free

Analyst Opinions

23 Analysts have issued a Hologic forecast:

7x Buy
30%
15x Hold
65%
1x Sell
4%

Analyst Opinions

23 Analysts have issued a Hologic forecast:

Buy
30%
Hold
65%
Sell
4%

Financial data from Hologic

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
4,039 4,039
2% 2%
100%
- Direct Costs 1,780 1,780
1% 1%
44%
2,259 2,259
4% 4%
56%
- Selling and Administrative Expenses 721 721
11% 11%
18%
- Research and Development Expense 266 266
7% 7%
7%
1,272 1,272
3% 3%
31%
- Depreciation and Amortization 295 295
10% 10%
7%
EBIT (Operating Income) EBIT 977 977
8% 8%
24%
Net Profit 744 744
44% 44%
18%

In millions USD.

Don't miss a Thing! We will send you all news about Hologic directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Hologic Stock News

Neutral
Business Wire
17 days ago
MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #governance--Wayde McMillan Elected to Hologic Board of Directors.
Neutral
Business Wire
18 days ago
MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #earnings--Hologic to Announce Financial Results for the Second Quarter of Fiscal 2025 on Thursday, May 1, 2025.
Neutral
Business Wire
about 2 months ago
MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #holx--Hologic to Webcast Presentation at the Raymond James 46th Annual Institutional Investors Conference.
More Hologic News

Company Profile

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. It operates through the following business segments: Breast Health, Diagnostics, Medical Aesthetics, GYN Surgical, and Skeletal Health. The Breast Health segment includes a broad portfolio of breast imaging and related products and accessories, including digital mammography systems, computer-aided detection, for mammography and minimally invasive breast biopsy devices, breast biopsy site markers, and breast biopsy guidance systems. The Diagnostics segment comprises Aptima family of Assays, target capture/nucleic acid extraction techonolgy, transcription-mediated amplification technology, hybridization protection assay and dual kinetic assat technologies, instrumentation, and Invader Chemistry Platform. The Medical Aesthetics segment offers SculpSure; PicoSure, MedLite, and RevLite; and MonaLisa Touch. The GYN Surgical segment encompasses the NovaSure Endometrial Ablation System and the MyoSure Hysteroscopic Tissue Removal System. The Skeletal Health segment covers the discovery and horizon X-ray bone densitometry system, an ultrasound-based osteoporosis assessment product, and Fluoroscan mini C-arm imaging products. The company was founded by S. David Ellenbogen and Jay A. Stein in 1986 and is headquartered in Marlborough, MA.

Head office United States
CEO Stephen MacMillan
Employees 7,063
Founded 1985
Website www.hologic.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today